How is industry capacity trending, and what is the outlook for outsourcing? A recent study by BioPlan Associates reveals key ...
The Pharmaceutical Research and Manufacturers of America has filed a complaint that challenges the US government’s MFN drug ...
BD (Becton, Dickinson and Company), a medical technology company, has announced a partnership with the US government under which the company has agreed to invest $19 billion in the ...
AstraZeneca has announced the opening of a new $1-billion global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The center is part of the company’s ...
How are small-molecules faring in 2026? To answer that question, DCAT Value Chain Insights examined where the small-molecules drugs among the 11 drugs identified by Clarivate, a business intelligence ...
The White House is moving to identify new and unused domestic, US-based, and near-shore production capacity to meet a goal of localizing manufacturing of essential medicines. The White House is moving ...
What is the state-of-the state for biomanufacturing (drug substance) in terms of industry capacity utilization, in-sourced/outsourced activity, and technology drivers? Is capacity in line with demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results